SHANGHAI, Dec. 9 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd. (ChemPartner) a wholly owned subsidiary of ShangPharmaCorporation, today announced that ChemPartner scientists are pleased to have been involved in recent groundbreaking cancer research from Agios Pharmaceuticals through the companies' ongoing partnership. This breakthrough discovery by Agios scientists
"The important discovery by Agios and the publication of the Nature article solidifies Agios' leading role in cancer metabolism," Michael Hui, founder and CEO of ChemPartner commented. "ChemPartner has been providing integrated drug discovery research support in the areas of protein science, HTS, enzymology, cell biology, in vivo pharmacology, and DMPK to Agios' innovative R&D programs in the emerging field of cancer metabolism. We congratulate the great achievement by Agios scientists and are also proud of the contribution we made to this partnership. This also demonstrates the quality of scientific work performed at ChemPartner. We look forward to continuing to help Agios advance its drug discovery programs and pipelines."
"The flexibility and expertise of our partners enabled Agios scientists to make this discovery very quickly," said Michael Su, VP Drug Discovery and Interim CSO at Agios Pharmaceuticals. "This new understanding of IDH1 mutants has opened up a new strategy for treating certain forms of cancer. ChemPartner's scientific capabilities will facilitate the continued progress of our drug discovery programs and shorten the time to bring new cancer therapeutics to patients."
About Shanghai ChemPartner
Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 120 pharmaceutical and biotech companies in the world. ChemPartner currently has a team of over 1,000 scientists including over 90 senior scientific leaders with extensive industry experiences gained from leading global pharmaceutical and biotech companies.
Further information is available at http://www.shangpharma.com .
SOURCE Shanghai ChemPartner Co., Ltd.
Subscribe to our Free Newsletters!
Pets can give you diseases. Surprised? You may love your pet but beware! Your pets might be ...
Water is essential to balance body fluids, boost brain function, improve digestion, prevent ...
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...View All